Average Co-Inventor Count = 2.90
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Celera Corporation (4 from 98 patents)
2. Academisch Ziekenhuis Leiden (4 from 47 patents)
3. Rijksuniversiteit Leiden (3 from 22 patents)
4. Akzo Nobel N.v. (1 from 1,248 patents)
5. Lieden University Medical Center (Lumc) (1 from 1 patent)
12 patents:
1. 12083170 - Prohemostatic proteins for the treatment of bleeding
2. 11357836 - Prohemostatic proteins for the treatment of bleeding
3. 11304995 - Prohemostatic proteins for the treatment of bleeding
4. 11124834 - Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
5. 10537618 - Prohemostatic proteins for the treatment of bleeding
6. 8227189 - Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
7. 8071291 - Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
8. 7910303 - Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
9. 6558913 - Method for screening for the presence of genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein C
10. 6518016 - Method for diagnosing an increased risk for thrombosis or a genetic defect causing thrombosis and kit for use with the same
11. 5910576 - Method for screening for the presence of a genetic defect associated
12. 5874256 - Method for diagnosing an increased risk for thrombosis or a genetic